Page last updated: 2024-12-08
cyanex 272
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Cyanex 272: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 157898 |
| CHEMBL ID | 1476841 |
| SCHEMBL ID | 186893 |
| MeSH ID | M0513964 |
Synonyms (23)
| Synonym |
|---|
| NCGC00166110-01 |
| 83411-71-6 |
| bis(2,4,4-trimethylpentyl)phosphinic acid |
| bis(2,4,4-trimethylpentyl)-phosphinic acid |
| phosphinic acid, bis(2,4,4-trimethylpentyl)- |
| phosphinic acid, p,p-bis(2,4,4-trimethylpentyl)- |
| einecs 280-445-7 |
| ec 280-445-7 |
| cyanex 272 |
| FT-0689045 |
| CHEMBL1476841 |
| SCHEMBL186893 |
| W-111573 |
| AKOS024438132 |
| bis(2,4,4-trimethylpentyl)phosphinicacid |
| c16h35o2p |
| J-016844 |
| p,p-bis(2,4,4-trimethylpentyl)phosphinic acid |
| DTXSID60868724 |
| CS-0032791 |
| mfcd28145690 |
| SY113742 |
| A864266 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (2)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 5.6234 | 0.0032 | 45.4673 | 12,589.2998 | AID2517 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 89.1251 | 0.3548 | 28.0659 | 89.1251 | AID504847 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 43.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (43.75) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||